Spring breezes bring good news, and new honors add fresh luster. From April 24 to 26, 2026, the 4th STAAR Surgical EVO ICL APAC Experts Summit was grandly held in Guangzhou, China. As one of the most high-standard and influential academic exchange platforms in the field of refractive ophthalmology, the summit gathered top ophthalmology experts, scholars and industry elites from the 

Asia-Pacific region and across the globe to discuss cutting-edge achievements in refractive correction.

Director Chen Xiaobei from the Refractive Surgery Department of Dongguan Aier Eye Hospital, Member of the National Youth Expert Cooperation Group for Phakic Posterior Chamber Intraocular Lens Implantation and Deputy Leader of the Youth Cooperation Group of the Refractive Optics Committee of Aier Eye Hospital Group, was invited to attend the event. She conducted in-depth academic exchanges with experts from China, the United States, Japan, South Korea, Singapore and other countries, fully demonstrating China’s professional strength and industry influence in the field of ICL diagnosis and treatment.

Outstanding Achievements & Triumphant Return

Director Chen Xiaobei Awarded Three International Honors

Drawing on nearly 20 years of clinical experience in ophthalmology, exquisite surgical skills and outstanding contributions to ICL technology, Director Chen Xiaobei has earned wide recognition from peers and heartfelt praise from patients. She has been conferred three major individual international awards: the ICL 5,000-Case Surgical Quality Contribution Award, the TICL 3,000-Case Surgical Quality Contribution Award, and the Young EVO ICL Ophthalmologist Award, further consolidating her leading position in refractive surgery.

• Director Chen Xiaobei – Recipient of the ICL 5,000-Case Surgical Quality Contribution Award

  
  

  
  

  
  

• Director Chen Xiaobei – Recipient of the TICL 3,000-Case Surgical Quality Contribution Award

  
  

• Director Chen Xiaobei – Recipient of the Young EVO ICL Ophthalmologist Award

  
  

These three prestigious trophies stand testament to Director Chen Xiaobei’s unparalleled expertise in ICL surgery, marked by consistently leading surgical volume and profound experience accumulated through numerous clinical cases. The honors not only affirm her impeccable safety record in ICL procedures but also reflect the trust placed in her by countless patients pursuing clear vision. From precise control over every surgical detail to promoting the standardized application of ICL technology nationwide, Director Chen Xiaobei safeguards clear vision with meticulous craftsmanship and delivers outstanding medical outcomes in refractive care with solid expertise.

Forging Ahead with Honors, Illuminating the Future

10,000 ICL Surgeries Certified by Chen Xiaobei’s Team | Setting the Benchmark for Refractive Care in Dongguan

Reaching the milestone of over 10,000 ICL surgeries demands exceptional surgical proficiency, as ICL implantation requires stringent qualifications, extensive experience and ultra-precise operation.

This remarkable milestone stems from the team’s rich experience, rigorous medical attitude, and persistent technical refinement. It is also strongly supported by globally synchronized medical equipment, standardized pre-operative evaluation protocols and refined post-operative management. This outstanding track record has won the trust of millions of myopic patients in Dongguan and surrounding areas, fully proving the comprehensive advantages of Director Chen Xiaobei’s team in expert strength, cutting-edge technology and premium medical services.

Upgrade Your High-Definition Vision!

The First Officially Certified Hospital for EVO+ICL (V5) in Dongguan

With the rapid advancement of myopia correction technology, the newly popular EVO+ICL (V5) – renowned for all-day high-definition vision – has gained widespread attention and popularity among myopic groups. Thanks to strict official certification and the active promotion by President Liu Fei and Director Chen Xiaobei, our hospital has become the first officially certified medical institution for EVO+ICL (V5) in Dongguan, with priority access to product ordering rights. As one of the first batch of nationally certified surgeons and the first expert in Dongguan with international certification for this next-generation technology, Director Chen Xiaobei enables local residents to access the world’s latest ICL cutting-edge technology locally.

Core Advantages of the New-Generation V5 Lens vs. V4c

Empowered by ARTEVO 800 3D Navigation System

In July 2025, Dongguan Aier Eye Hospital exclusively introduced the first ARTEVO 800 3D digital navigation surgical microscope in Dongguan. Integrating 3D digital optics, intra-operative assisted navigation and intraoperative OCT navigation, this device presents ultra-fine ocular structures through a 4K ultra-high-definition display. Meanwhile, it greatly reduces intra-operative light intensity, effectively improving patient comfort and cooperation during surgery.

Widely applied in ICL lens implantation, the ARTEVO 800 delivers a more precise, intelligent, safe and comfortable lens removal experience with disruptive upgrades. It comprehensively optimizes surgical outcomes and patient satisfaction for various intraocular lens procedures.

From the introduction of V5 technology and the accumulation of 10,000 successful ICL surgeries to the achievement of three international honors, Director Chen Xiaobei’s team leads the refractive industry in Dongguan with superior surgical skills. Centering on expert teams, cutting-edge technologies and patient needs, the team keeps pace with global medical advancements and focuses on localized high-quality medical services.